home > news > detailed info

York Health Economics Consortium offers an updated training event


Identifying Evidence for NICE Economic Submissions Training Day

Health economics evidence is a key element in much health services research and particularly in health technology assessments, including submissions for NICE single technology appraisals. Identifying economic evidence to inform submissions involves searches in a range of databases and uses a variety of strategies.

YHEC’s one-day Identifying Evidence for NICE Economic Submissions course, running on the 5th September 2018, provides an introduction to key databases and search approaches. It includes a ‘jargon buster’ session on the basics of health economics and economic models. It also features presentations about key economics information resources including the CEA Registry, and explorations of approaches to searching to identify data for economic models. With the closure of key economic evaluation databases (NHS EED and HEED), we will be focusing on how to identify economic evaluations from major bibliographic databases such as MEDLINE. There will be opportunities for hands-on practice, and by the end of the training day participants will have:

  • An awareness of the basic concepts of health economics and economic models
  • An understanding of the content and approaches of selected key health economics resources
  • An awareness of the search options available to access these resources
  • Experience of searching the resources

This study day would be of interest to researchers and information professionals seeking more insight into the sources of health economics information and its uses.

Price: £200 +(£40 VAT). Registration fee includes tea and coffee, lunch and course documentation. Paying by PayPal will confirm your place immediately.

University of York, Heslington, York YO10 5DD.
or telephone +44 (0)1904 323620
phone +44 (0)1904 323620
email Address: YHEC, Enterprise House, Innovation Way, University of York, York, YO10 5NQ, United Kingdom
Print this page
Send to a friend
News and Press Releases

ChemAxon and AWS simplify getting scientists moving on the cloud

Listen to a talk by Paul Underwood of AWS introducing Biotech Blueprint, a cloud based solution for cheminformatics. The technology for novel compound registration is provided by ChemAxon.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement